Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris.

NCT01536886 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01536886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris.
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
November 30, 2012
Enrollment
376 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris